UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma

PloS one, 2014-08, Vol.9 (8), p.e106249

2014

Link zum Volltext

Verfügbarkeit prüfen

Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

Cancer, 2008-05, Vol.112 (10), p.2119-2129

2008

Link zum Volltext

Verfügbarkeit prüfen

Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma

Clinical cancer research, 2005-04, Vol.11 (7), p.2561-2567

2005

Link zum Volltext

Verfügbarkeit prüfen

FCGR2A Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2885-2890

2006

Link zum Volltext

Verfügbarkeit prüfen

An expression signature classifies chemotherapy-resistant pediatric osteosarcoma

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1748-1754

2005

Link zum Volltext

Verfügbarkeit prüfen

Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma

International journal of cancer, 2004-03, Vol.109 (1), p.106-111

2004

Link zum Volltext

Verfügbarkeit prüfen

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance

Molecular cancer therapeutics, 2009-05, Vol.8 (5), p.1037-1044

2009

Link zum Volltext

Verfügbarkeit prüfen

The Folate Receptor α Is Frequently Overexpressed in Osteosarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate

Clinical cancer research, 2007-05, Vol.13 (9), p.2557-2567

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of the Cyclin-Dependent Kinase Inhibitor and Protein Kinase C Inhibitor 7-Hydroxystaurosporine in Combination With Fluorouracil in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1875-1884

2005

Link zum Volltext

Verfügbarkeit prüfen

Elevated Physiologic Tumor Pressure Promotes Proliferation and Chemosensitivity in Human Osteosarcoma

Clinical cancer research, 2005-03, Vol.11 (6), p.2389-2397

2005

Link zum Volltext

Verfügbarkeit prüfen

Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

Cancer, 2014-02, Vol.120 (4), p.548-554

2014

Link zum Volltext

Verfügbarkeit prüfen

Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma

Journal of orthopaedic research, 2008-11, Vol.26 (11), p.1520-1525

2008

Link zum Volltext

Verfügbarkeit prüfen

Methylthioadenosine Phosphorylase Gene Deletions Are Common in Osteosarcoma

Clinical cancer research, 2002-03, Vol.8 (3), p.782-787

2002

Link zum Volltext

Verfügbarkeit prüfen

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples

Sarcoma, 2011, Vol.2011, p.834170-5

2011

Link zum Volltext

Verfügbarkeit prüfen

Sequence Alterations in the Reduced Folate Carrier Are Observed in Osteosarcoma Tumor Samples

Clinical cancer research, 2003-02, Vol.9 (2), p.837-844

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1692: Expression of argininosuccinate synthetase protein and correlation with response to the novel therapeutic pegylated arginine deiminase (ADI-PEG20) in osteosarcoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1692-1692

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model

Genes & cancer, 2017-01, Vol.8 (1-2), p.484-494

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5520: Novel therapy NKP-1339 is active in osteosarcoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5520-5520

2013

Link zum Volltext

Verfügbarkeit prüfen

Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Osteosarcoma

Cancer, 2013-10, Vol.120 (4), p.548-554

2013

Link zum Volltext

Verfügbarkeit prüfen

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study

Pediatric blood & cancer, 2014-09, Vol.61 (9), p.1558-1564

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5332: Evaluation of GD2 expression in patients with osteosarcoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5332-5332

2011

Link zum Volltext

Verfügbarkeit prüfen

Over‐expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma

International journal of cancer, 2007-09, Vol.121 (5), p.943-954

2007

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3403: Responsiveness to IGF-1R targeted therapy in osteosarcoma may be regulated by the 3179 G>A mutation

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3403-3403

2010

Link zum Volltext

Verfügbarkeit prüfen

Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma

Clinical cancer research, 2001-10, Vol.7 (10), p.3065-3070

2001

Link zum Volltext

Verfügbarkeit prüfen

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study: HER-2 Expression in Osteosarcoma

Pediatric blood & cancer, 2014-09, Vol.61 (9), p.1558-1564

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(86)
Bücher
(2)

Sprache

Englisch
(88)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Humans
(38)
Female
(30)
Biological And Medical Sciences
(26)
Male
(25)
Medical Sciences
(20)
Middle Aged
(20)
Oncology
(19)
Adult
(18)
Animals
(14)
Child
(14)
Adolescent
(12)
Diseases Of The Osteoarticular System
(11)
Osteosarcoma
(11)
Tumors Of Striated Muscle And Skeleton
(11)
Osteosarcoma - Metabolism
(10)
Osteosarcoma - Pathology
(9)
Child, Preschool
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma

Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma

FCGR2A Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

An expression signature classifies chemotherapy-resistant pediatric osteosarcoma

Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance

The Folate Receptor α Is Frequently Overexpressed in Osteosarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate

Phase I Trial of the Cyclin-Dependent Kinase Inhibitor and Protein Kinase C Inhibitor 7-Hydroxystaurosporine in Combination With Fluorouracil in Patients With Advanced Solid Tumors

Elevated Physiologic Tumor Pressure Promotes Proliferation and Chemosensitivity in Human Osteosarcoma

Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma

Methylthioadenosine Phosphorylase Gene Deletions Are Common in Osteosarcoma

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples

Sequence Alterations in the Reduced Folate Carrier Are Observed in Osteosarcoma Tumor Samples

Abstract 1692: Expression of argininosuccinate synthetase protein and correlation with response to the novel therapeutic pegylated arginine deiminase (ADI-PEG20) in osteosarcoma

Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model

Abstract 5520: Novel therapy NKP-1339 is active in osteosarcoma

Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Osteosarcoma

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study

Abstract 5332: Evaluation of GD2 expression in patients with osteosarcoma

Over‐expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma

Abstract 3403: Responsiveness to IGF-1R targeted therapy in osteosarcoma may be regulated by the 3179 G>A mutation

Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study: HER-2 Expression in Osteosarcoma

Suchergebnisse filtern